Inherited thrombophilia and pregnancy associated venous thromboembolism

作者: Wendy Lim , John W Eikelboom , Jeffrey S Ginsberg

DOI: 10.1136/BMJ.39205.484572.55

关键词:

摘要: Pulmonary embolism is the leading cause of maternal mortality in developed countries and accounts for 20% pregnancy related deaths United States.1 2 The risk pulmonary deep vein thrombosis, collectively known as venous thromboembolism, increased during further by presence inherited or acquired thrombophilias. We summarise epidemiology diagnosis thromboembolism discuss anticoagulant management women with thrombophilia who are at of, develop, postpartum period. #### Scenario A 30 year old woman, a heterozygote factor V Leiden mutation, presents eight weeks' gestation her first wondering whether she should receive prophylactic anticoagulation to prevent recurrent thrombosis pregnancy. Several years ago left leg after an ankle fracture prolonged immobilisation was found have mutation. treated anticoagulants three months, woman has had no thromboembolic events since stopping warfarin. Her mother surgery but did not undergo testing thrombophilia. #### Methods We searched Medline Cochrane database systematic reviews studies evaluating epidemiology, diagnosis, prevention, treatment period thrombophilia, using key words “venous thrombosis”, “deep “pulmonary embolism”, “pregnancy (complications)”, “thrombophilia”, “anticoagulants.” Venous occurs 10 per 100 000 childbearing age affects 100 pregnancies.3 Inherited present 30%-50% associated thromboembolism,3w1 being most frequently identified white population (table 1⇓). #### Non-inherited conditions that increase pregnancy ##### General conditionsw2

参考文章(16)
J S Ginsberg, P Brill-Edwards, R F Burrows, R Bona, P Prandoni, H R Büller, A Lensing, Venous thrombosis during pregnancy: leg and trimester of presentation. Thrombosis and Haemostasis. ,vol. 67, pp. 519- 520 ,(1992) , 10.1055/S-0038-1648485
F. Brian Pascual, Lynn R. Zanardi, Margaret M. Cortese, Emily L. Mcginley, Trudy V. Murphy, Tetanus surveillance--United States, 1998--2000. Morbidity and Mortality Weekly Report. ,vol. 52, pp. 1- 8 ,(2003)
Ingrid Pabinger, Paul A Kyrle, Max Heistinger, Sabine Eichinger, Eva Wittmann, Klaus Lechner, The risk of thromboembolism in asymptomatic patients with protein C and protein S deficiency: a prospective cohort study Thrombosis and Haemostasis. ,vol. 71, pp. 441- 445 ,(1994) , 10.1055/S-0038-1642457
Judith G. Hall, Richard M. Pauli, Kathleen M. Wilson, Maternal and fetal sequelae of anticoagulation during pregnancy The American Journal of Medicine. ,vol. 68, pp. 122- 140 ,(1980) , 10.1016/0002-9343(80)90181-3
I Pabinger, L Nemes, C Rintelen, S Koder, E Lechler, R M Loreth, P A Kyrle, I Scharrer, G Sas, K Lechner, C Mannhalter, S Ehrenforth, Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V Leiden. Hematology Journal. ,vol. 1, pp. 37- 41 ,(2000) , 10.1038/SJ.THJ.6200005
Carine Ronsmans, Wendy J Graham, Maternal mortality: who, when, where, and why The Lancet. ,vol. 368, pp. 1189- 1200 ,(2006) , 10.1016/S0140-6736(06)69380-X
Isobel D Walker, M Greaves, F. E Preston, Investigation and management of heritable thrombophilia. British Journal of Haematology. ,vol. 114, pp. 512- 528 ,(2001) , 10.1046/J.1365-2141.2001.02981.X
Donna Dizon-Townson, Connie Miller, Baha Sibai, Catherine Y Spong, Elizabeth Thom, George Wendel Jr, Katharine Wenstrom, Philip Samuels, Margaret A Cotroneo, Atef Moawad, Yoram Sorokin, Paul Meis, Menachem Miodovnik, Mary J O’Sullivan, Deborah Conway, Ronald J Wapner, Steven G Gabbe, National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network, The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstetrics & Gynecology. ,vol. 106, pp. 517- 524 ,(2005) , 10.1097/01.AOG.0000173986.32528.CA
Saskia Middeldorp, Eduard J. Libourel, Karly Hamulyák, Jan Van Der Meer, Harry R. Büller, The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden British Journal of Haematology. ,vol. 113, pp. 553- 555 ,(2001) , 10.1046/J.1365-2141.2001.02766.X
Linda A Barbour, Jeffrey M Smith, Richard A Marlar, Heparin levels to guide thromboembolism prophylaxis during pregnancy American Journal of Obstetrics and Gynecology. ,vol. 173, pp. 1869- 1873 ,(1995) , 10.1016/0002-9378(95)90443-3